Author Interviews, Flu - Influenza, NEJM, Pediatrics, Vaccine Studies / 15.12.2013
Flu: Vaccine For Prevention in Children
MedicalResearch.com Interview with:
Ghassan Dbaibo, M.D., FAAP
Professor and Vice-Chair for Research and Faculty Development
Department of Pediatrics and Adolescent Medicine
Head, Division of Pediatric Infectious Diseases
Director, Center for Infectious Diseases Research
Professor, Department of Biochemistry and Molecular Genetics
American University of Beirut Beirut, Lebanon
MedicalResearch.com: What are the main findings of the study?
Dr. Dbaibo:
- 55% efficacy (95% CI 39–67%) for prevention of all influenza
- These results are comparable with other estimates of efficacy and effectiveness for trivalent inactivated flu vaccines in this age group
- 73% efficacy (97.5% CI 47–86%) for prevention of moderate-to-severe influenza
- By preventing moderate-to-severe influenza, vaccination prevented the most clinically consequential outcomes of infection, reducing hospitalisations by 75% and medical visits by 69%.
- Seroprotection rates of more than 95% for each of the four influenza strains in the vaccine
- An acceptable safety and reactogenicity profile













